Gevo (GEVO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Gevo Reports Fourth Quarter 2015 Financial Results
March 29, 2016 7:10 AM EDTGevo Restarts Production of Isobutanol in March 2016 Following Completion of Capital Projects
- Gevo to Host Conference Call Today at 5:30 EDT/3:30 MDT -
Reports EPS of ($0.44) for the fourth quarterEnded the fourth quarter with cash and cash equivalents of $17.0 millionReports revenue of $7.3 million for the quarterReports non-GAAP cash EBITDA loss* of $4.2 million for the quarterENGLEWOOD, Colo., March 29, 2016 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the three months ended December 31, 2015. Key highlights for Gevo... More
Gevo Announces Pricing of $3.5 Million Public Offering of Common Stock and Warrants
March 29, 2016 7:01 AM EDTENGLEWOOD, Colo., March 29, 2016 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it has priced its underwritten public offering of common stock and warrants.
Gevo announced that it has agreed to sell 3,721,429 Series C units, with each Series C unit consisting of one share of common stock, one Series F warrant to purchase one share of common stock and two Series H warrants, each to purchase one share of common stock, at a public offering price of $0.35 per Series C unit. Gevo has... More



